BioAtla (BCAB) Enterprise Value (2020 - 2025)
BioAtla's Enterprise Value history spans 6 years, with the latest figure at -$4.3 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 88.92% year-over-year to -$4.3 million; the TTM value through Dec 2025 reached -$4.3 million, up 88.92%, while the annual FY2025 figure was -$4.3 million, 88.92% up from the prior year.
- Enterprise Value reached -$4.3 million in Q4 2025 per BCAB's latest filing, up from -$8.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$4.3 million in Q4 2025 to a low of -$269.9 million in Q3 2021.
- Average Enterprise Value over 5 years is -$130.6 million, with a median of -$155.0 million recorded in 2023.
- Peak YoY movement for Enterprise Value: plummeted 112730.98% in 2021, then surged 88.92% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$245.0 million in 2021, then rose by 12.03% to -$215.5 million in 2022, then skyrocketed by 76.61% to -$50.4 million in 2023, then rose by 23.02% to -$38.8 million in 2024, then soared by 88.92% to -$4.3 million in 2025.
- Per Business Quant, the three most recent readings for BCAB's Enterprise Value are -$4.3 million (Q4 2025), -$8.3 million (Q3 2025), and -$18.2 million (Q2 2025).